Journal of Medical Diagnostic Methods
Open Access

Abstract

Alzheimer's disease is a type of dementia

Glamora Swiss

Alzheimer's disease is one of the most debilitating brain diseases that affect the elderly. It's an illness that's undertreated and underappreciated, but it's quickly becoming a big public health issue. Efforts to uncover the origin of the condition and create pharmacological treatments have progressively increased during the last decade. Improvements in clinical diagnostic standards and treatment of both cognitive and behavioral issues have been made in recent years. Symptomatic treatment, primarily cholinergic therapy, has been clinically tested in randomized, double-blind, placebo-controlled, parallel-group studies assessing performance-based cognitive functions. Cholinesterase inhibitors such as donepezil, tacrine, rivastigmine, and galantamine are advised for people with Alzheimer's disease who are experiencing cognitive difficulties Alzheimer's disease is one of the most debilitating brain diseases that affect the elderly. It's an illness that's undertreated and underappreciated, but it's quickly becoming a big public health issue. Efforts to uncover the origin of the condition and create pharmacological treatments have progressively increased during the last decade. Improvements in clinical diagnostic standards and treatment of both cognitive and behavioral issues have been made in recent years. Symptomatic treatment, primarily cholinergic therapy, has been clinically tested in randomized, double-blind, placebo-controlled, parallel-group studies assessing performance-based cognitive functions. Cholinesterase inhibitors such as donepezil, tacrine, rivastigmine, and galantamine are advised for people with Alzheimer's disease who are experiencing cognitive difficulties

Published Date: 2021-09-27; Received Date: 2021-09-04